메뉴 건너뛰기




Volumn 7, Issue 1, 2001, Pages 58-67

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 6;

EID: 0035135625     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)

References (45)
  • 2
    • 0024814903 scopus 로고
    • Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response
    • (1989) Lab. Investig. , vol.61 , pp. 588-602
    • Le, J.1    Vilcek, J.2
  • 4
    • 0002229197 scopus 로고
    • Interleukin-6: Multifunctional cytokine
    • V. T. Devita, S. Hellman, and S. A. Rosenberg (eds.), Biologic Therapy of Cancer Updates, Vol. 3. Hagerstown, MD: J. B. Lippincott Company
    • (1993) , pp. 1-9
    • Weber, J.1
  • 34
    • 0029609110 scopus 로고
    • Recombinant human interleukin-6: Safety issues of a pleiotropic growth factor
    • (1995) Toxicology , vol.105 , pp. 91-107
    • Kammüller, M.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.